In some countries, this medicine may only be approved for veterinary use.
In the US, Cosmegen (dactinomycin systemic) is a member of the drug class antibiotics/antineoplastics and is used to treat Cancer, Ewing's Sarcoma, Osteoarthritis, Osteosarcoma, Ovarian Cancer, Rhabdomyosarcoma, Testicular Cancer, Trophoblastic Disease and Wilms' Tumor.
US matches:
- Cosmegen
Ingredient matches for Cosmegen
Dactinomycin is reported as an ingredient of Cosmegen in the following countries:
- Argentina
- Australia
- Austria
- Bahrain
- Brazil
- Bulgaria
- Egypt
- Estonia
- Hong Kong
- Iran
- Iraq
- Japan
- Jordan
- Kuwait
- Lebanon
- New Zealand
- Norway
- Oman
- Philippines
- Qatar
- Saudi Arabia
- Switzerland
- Syria
- Taiwan
- Turkey
- United Arab Emirates
- United Kingdom
- United States
- Yemen
International Drug Name Search